
HPQ's Latest Pilot Test Delivers Higher-Purity, Higher-Quality Fumed Silica While Validating Semi-Continuous Reactor Operation
HPQ Silicon Inc.
('HPQ' or the 'Company') (TSX-V:
HPQ
, OTCQB:
HPQFF
, FRA:
O08
), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders that it has received new results from a leading global fumed silica manufacturer ('LGFSM') regarding the evaluation of materials produced during Phase 1 Test #5.
Milestones: First Production of Material under Semi-Continuous Feedstock Feeding Protocol
Technology supplier,
PyroGenesis Inc.
(TSX:
PYR
, OTCQX:
PYRGF
, FRA:
8PY1
) has informed the Company that, in addition to successfully replicating the production and collection of material in the dedicated product recovery unit (commonly referred to as the 'baghouse'), HPQ Silica Polvere Inc.'s (HSPI)[1] proprietary Fumed Silica Reactor (FSR) pilot plant operated under a semi-continuous feeding approach during Phase 1 Test #5 — two key steps in advancing the FSR toward commercial validation.
Significant Improvement Achieved in the Purity and Quality of Fumed Silica Produced
Material analysis conducted by the Leading Global Fumed Silica Manufacturer (LGFSM) confirmed several notable improvements in the fumed silica produced during Phase 1 Test #5 compared to Test #4:
'Taken together, the results from Phase 1 tests 4 and 5, along with operational data from the three earlier tests,
validate the successful 20-fold scale-up of the Fumed Silica Reactor—from lab to pilot scale, and from batch to semi-continuous production
,'
said Bernard Tourillon, President and CEO of HPQ Silicon and HPQ Silica Polvere Inc. '
These results confirm that key material properties can be reliably reproduced and even improved at larger scale, establishing a solid foundation for future process optimization
.'
Phase 2 Testing to Focus on Advancing Material Surface Area Performance
With the successful validation of process replicability at pilot scale, testing is now progressing into Phase 2, which will focus on further improving the material's surface area. The upcoming tests aim to produce fumed silica materials with BET surface areas up to 300 m²/g.
'Having overcome the key technical challenges to reach this Phase 1 completion milestone, we believe the remaining steps—specifically achieving the targeted surface area range with the FSR—are now well within reach,'
added Mr. Tourillon.
Image 1) Material produced and collected in the baghouse, during Phase 1 Test #5, and
sent to the leading global fumed silica manufacturer under the LOI
.
'
With Phase 1 testing successfully completed, we now look forward to the launch of Phase 2 with great anticipation,'
added Mr. Tourillon.
REFERENCE SOURCES
About HPQ Silicon
HPQ Silicon Inc.
(
TSX-V: HPQ
) is a Quebec-based TSX Venture Exchange Industrial Issuer.
HPQ is a technology company focused on innovation in advanced materials and critical process development. In partnership with world-class technology leaders
PyroGenesis Inc.
and
NOVACIUM SAS
—of which HPQ is a shareholder—the company is developing the materials and process technologies essential to achieving net-zero goals.
HPQ activities are centred around the following pillars:
For more information, please visit
HPQ Silicon web site
.
About PyroGenesis Inc.
PyroGenesis, a high-tech company, is a proud leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions which reduce greenhouse gases (GHG) and are economically attractive alternatives to conventional 'dirty' processes. PyroGenesis has created proprietary, patented and advanced plasma technologies that are being vetted and adopted by multiple multibillion dollar industry leaders in four massive markets: iron ore pelletization, aluminum, waste management, and additive manufacturing. With a team of experienced engineers, scientists and technicians working out of its Montreal office, and its 3,800 m2 and 2,940 m2 manufacturing facilities, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The operations are ISO 9001:2015 and AS9100D certified, having been ISO certified since 1997. PyroGenesis' shares are publicly traded on the TSX in Canada (TSX: PYR), the OTCQX in the US (OTCQX: PYRGF), and the Frankfurt Stock Exchange in Germany (FRA: 8PY).
www.pyrogenesis.com
Cautionary
Note
Regarding
Forward-Looking
Information
This press release contains 'forward-looking information' and 'forward-looking statements' within the meaning of applicable securities legislation (collectively, 'forward-looking statements'), including, but not limited to, statements relating to future financial or operating events or future performance of the Company, and reflecting management's expectations and assumptions regarding the Company's growth, results, performance, and business prospects and opportunities. Such forward-looking statements reflect management's current beliefs and are based on information currently available to it. In some cases, forward-looking statements can be identified by words such as 'aim', 'anticipate', 'aspire', 'attempt', 'believe', 'budget', 'could', 'estimate', 'expect', 'forecast', 'intend', 'may', 'mission', 'plan', 'potential', 'predict', 'progress', 'outlook', 'schedule', 'should', 'study', 'target', 'will', 'would' or the negative of these terms or other similar expressions concerning matters that are not historical facts.
In particular, forward-looking statements include, but are not limited to, the Company's ability to develop
its low-cost (Capex and Opex) manufacturing of Fumed Silica using its Fumed Silica Reactor (FSR)
and enter in commercial production within the timeline, to provide high-performing and reliable advanced materials while promoting sustainability and supply chain traceability, and to position its fumed silica operation in the capital markets, the expected results of the initiatives described in this press release, and those statements which are discussed under the 'About HPQ Silicon' paragraph and elsewhere in the press release which essentially describe the Company's outlook and objectives.
Additionally, the forward-looking statements include, but are not limited to, the Company's future results, the intended pilot plant testing and timeline of the Fumed Silica Reactor commercial scale up, the economic performance and product development efforts, as well as the Company's expected achievement of milestones, including the ability to conclude an offtake agreement and obtain sufficient financing for the future development on favorable terms for the Company.
Further, these forward-looking statements include the Company's ability to achieve its Fumed Silica strategy and its intended results, market trends, the consumer demand for materials, the Company's competitive advantages, macroeconomic conditions, the impact of applicable laws and regulations, and any information as to future plans and outlook for the Company are or involve forward-looking statements.
Forward-looking statements are based on estimates and assumptions that, while considered reasonable by the Company at the time of such statements, are inherently subject to significant business, economic, and competitive uncertainties and contingencies. These estimates and assumptions are not guarantees of future performance and may prove incorrect. These statements rely on various factors, including current technological trends, safe and effective operations, timely delivery and installation of future production equipment at estimated prices, assumed Fumed Silica sale prices, future exchange and interest rates, political and regulatory stability, commodity prices and production costs, the receipt of necessary approvals, licenses, and permits on favorable terms, sustained labor stability, financial and capital market conditions, availability of critical supplies and equipment, tax assumptions, CAPEX and OPEX estimates, economic and operational projections, local infrastructure, and overall business prospects. Forward-looking statements are also subject to risks, uncertainties, and other factors that may cause actual results to differ materially, including the outcome of development, engineering, and planning activities, market conditions, competition, pricing pressures, risks inherent to mining exploration and development, the commercial viability of the Company's technology, project timelines, business continuity challenges, geopolitical instability, and other industry risks. Additionally, there can be no assurance that the conditions precedent of offtake agreements, product qualification requirements, and commercial operations will be met, nor that the Company will fulfill the expectations of financing partners and certifying bodies.
Forward-looking statements are subject to known or unknown risks and uncertainties that may cause actual results to differ materially from those anticipated or implied in the forward-looking statements. Risk factors that could cause actual results or events to differ materially from current expectations include, among others, delays in the scheduled delivery times of the equipment, the ability of the Company to successfully implement its strategic initiatives and whether such strategic initiatives will yield the expected benefits, the availability of financing or financing on favorable terms for the Company, the dependence on commodity prices, the impact of inflation on costs, the risks of obtaining the necessary permits, the operating performance of the Company's assets and businesses, competitive factors in the graphite mining and production industry, changes in laws and regulations affecting the Company's businesses, political and social acceptability risk, environmental regulation risk, currency and exchange rate risk, technological developments, as well as earnings, capital expenditure, cash flow and capital structure risks and general business risks. A further description of risks and uncertainties can be found in HPQ's Annual Information Form dated March 21, 2025, including in the section thereof captioned 'Risk Factors', which is available on SEDAR+ at
www.sedarplus.ca
Unpredictable or unknown factors not discussed in this Cautionary Note could also have material adverse effects on forward-looking statements.
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that may cause results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. The Company disclaims any intention or obligation to update or revise any forward-looking statements or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.
Market and industry data presented throughout this press release was obtained from third-party sources and industry reports, publications, websites and other publicly available information, as well as industry and other data prepared by the Company or on the behalf of the Company based on the Company's knowledge of the markets in which the Company operates, including information provided by suppliers, partners, customers and other industry participants.
The Company believes that the market and economic data presented throughout this press release is accurate as of the date of publication and, with respect to data prepared by the Company or on behalf of the Company, that estimates and assumptions are currently appropriate and reasonable, but there can be no assurance as to the accuracy or completeness thereof. The accuracy and completeness of the market and economic data presented throughout this press release are not guaranteed and the Company does not make any representation as to the accuracy of such data.
Actual outcomes may vary materially from those forecast in such reports or publications, and the prospect for material variation can be expected to increase as the length of the forecast period increases. Although the Company believes it to be reliable as of the date of publication, the Company has not independently verified any of the data from third-party sources referred to in this press release, analyzed or verified the underlying studies or surveys relied upon or referred to by such sources, or ascertained the underlying market, economic and other assumptions relied upon by such sources. Market and economic data are subject to variations and cannot be verified due to limits on the availability and reliability of data inputs, the voluntary nature of the data gathering process and other limitations and uncertainties inherent in any statistical survey.
Further information regarding the Company is available in the SEDAR+ database
(www.sedarplus.ca)
, and on the Company's website at:
www.hpqsilicon.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This News Release is available on the company's
CEO Verified Discussion Forum
, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Source: HPQ Silicon Inc.
For further information contact:
Bernard J. Tourillon, Chairman, President, and CEO
Tel +1 (514) 846-3271
Email:
Info@hpqsilicon.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/62e3ff11-8b52-4f31-8319-4b9bc557c999
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
9 minutes ago
- Business Wire
GenSight Biologics Announces the Closing of the Company's c. €4 Million Private Placement
PARIS--(BUSINESS WIRE)--Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA GenSight Biologics (the " Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the closing of its EUR 3,908,715.39 private placement (the ' Private Placement '). The Private Placement resulted in the issuance of 21,251,267 ordinary shares of the Company (the " Offered Shares"). The Offered Shares will be admitted to trading on Euronext Paris on July 3, 2025 (ISIN FR0013183985/SIGHT). The issuance of: The 1,850,000 pre-funded warrants (the " Offered Pre-Funded Warrants") giving the right to subscribe to 1,850,000 additional ordinary shares (the " Pre-Funded Warrant Shares"); and The 23,101,267 warrants (the " Offered Investor Warrants") giving the right to subscribe to 23,101,267 additional ordinary shares (the " Investor Warrant Shares") is expected to take place tomorrow, July 4, 2025. The Offered Investor Warrants will be admitted to trading on the Euronext Growth market in Paris (" Euronext Growth Paris") on July 7, 2025 (ISIN FR0014010IB4/SIGBS). The Offered Pre-Funded Warrants will not be admitted to trading on any venue. Part of the proceeds, EUR 0.7 million, has been used for the repayment in principal on the convertible bonds held by Heights Capital through offset against their subscription. Maxim Group, LLC acted as sole placement agent for the Private Placement in the United States, pursuant to an agreement entered into with the Company. Risk factors The Company draws the attention of the public to the risk factors relating to the Company and its business described in its 2024 Universal Registration Document, as amended by the Information Document published by the Company on July 1 st, 2025, both of which are available free of charge on the Company's website ( . About GenSight Biologics S.A. GenSight Biologics S.A. is a clinical-stage biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders. GenSight Biologics' pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics, to help preserve or restore vision in patients suffering from blinding retinal diseases. GenSight Biologics' lead product candidate, GS010 (lenadogene nolparvovec) is in Phase III in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and young adults. Using its gene therapy-based approach, GenSight Biologics' product candidates are designed to be administered in a single treatment to each eye by intravitreal injection to offer patients a sustainable functional visual recovery. Disclaimer Not for release, directly or indirectly, in or into the United States of America, Canada, Australia, Japan or South Africa. This press release and the information contained herein do not contain or constitute an offer to subscribe or purchase, or the solicitation of an order to purchase or subscribe, for securities in the United States of America or in any other jurisdiction where such an offer or solicitation would be unlawful. The securities referred to herein have not been and will not be registered under the Securities Act, or under the securities laws of any state or other jurisdiction of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the securities laws of any state or any other jurisdiction of the United States. GenSight does not intend to make a public offering of the securities in the United States of America. The distribution of this press release may be subject to legal or regulatory restrictions in certain countries. Persons in possession of this press release should inform themselves of and observe any local restrictions. The information contained herein is subject to change without notice. Forward-Looking Statements This press release contains forward-looking statements. All statements, other than statements of historical facts, included in this press release are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the completion expected proceeds and anticipated use of proceeds of the Private Placement; the anticipated cash runway of the Company; and future expectations, plans and prospects of the Company. Words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'projects,' and 'future' or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that the proposed securities offering discussed above will be consummated on the terms described or at all. Completion of the proposed Private Placement and the terms thereof are subject to numerous factors, many of which are beyond the control of the Company, including, without limitation, market conditions, failure of customary closing conditions and the risk factors and other matters set forth in the filings the Company makes with the AMF from time to time. The Company expressly disclaims any obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as may be required by law.


Business Wire
an hour ago
- Business Wire
ReNew Energy Global Plc Announces the Receipt of a Final Non-Binding Offer from Masdar, CPP Investments, ADIA and Sumant Sinha
GURUGRAM, India--(BUSINESS WIRE)--ReNew Energy Global Plc (' ReNew ' or the ' Company ') today announces that it has received a final non-binding offer dated July 2, 2025, from Abu Dhabi Future Energy Company PJSC-Masdar (' Masdar '), Canada Pension Plan Investment Board (' CPP Investments '), Platinum Hawk C 2019 RSC Limited as trustee for the Platinum Cactus A 2019 Trust (' Platinum Hawk ') (a wholly owned subsidiary of the Abu Dhabi Investment Authority, ' ADIA ') and Sumant Sinha (the Founder, Chairman and CEO of ReNew) (together with Masdar, CPP Investments and Platinum Hawk, the ' Consortium ') to acquire the entire issued and to be issued share capital of the Company not already owned by members of the Consortium for cash consideration of US$8.00 per share. This represents an increase of US$0.93 per share, equivalent to 13.2%, from the initial non-binding proposal dated December 10, 2024. The final non-binding offer represents a 26.2% premium versus the undisturbed share price of US$6.34 on December 10, 2024, being the closing share price prior to the initial non-binding proposal becoming public and a 38.9% premium to the 30-day volume-weighted average price of US$5.76 per share (as of December 10, 2024). As previously announced, the ReNew Board of Directors formed a Special Committee (' Special Committee ') led by Manoj Singh, the Lead Independent Director, consisting of the six independent non-executive ReNew Directors to consider the proposals received from the Consortium. The Special Committee is in the process of evaluating the final non-binding offer alongside its independent financial advisor, Rothschild & Co and independent legal counsel, Linklaters LLP. Active discussions with the Consortium remain ongoing and the Special Committee will provide an update to the market as soon as reasonably practicable. No assurance can be given regarding the likelihood, terms or details of a potential transaction resulting from the final non-binding offer received from the Consortium or any other potential transaction. Further decisions or disclosures by the Special Committee will be made as appropriate or required. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as 'estimate,' 'objective,' 'plan,' 'project,' 'forecast,' 'intend,' 'will,' 'expect,' 'anticipate,' 'believe,' 'seek,' 'target,' 'milestone,' 'designed to,' 'proposed' or other similar expressions that predict or imply future events, trends, terms and/or conditions or that are not statements of historical matters. The Company cautions readers of this press release that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the Company's control, that could cause the actual results to differ materially from the expected results. These forward-looking statements include, but are not limited to, statements regarding the Company's expectations regarding any proposal or offer received from the Consortium and uncertainty as to the pricing, timing or terms of any transaction with the Consortium or any other alternative transactions. Such forward-looking statements are based on current expectations and projections about future events and various assumptions. The forward-looking statements contained herein are also subject to other risks and uncertainties that are identified in the most recent Annual Report on Form 20-F filed with the United States Securities and Exchange Commission (the 'SEC') or Form 6-Ks furnished to the SEC by the Company. Forward-looking statements should, therefore, be construed in light of such risk factors and undue reliance should not be placed on forward-looking statements. These forward-looking statements speak only as of the date of this press release. The Company expressly disclaims any obligation or undertaking (except as required by applicable law) to release publicly any updates or revisions to any forward-looking statement contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. About ReNew ReNew is a leading decarbonization solutions company listed on Nasdaq (Nasdaq: RNW, RNWWW). ReNew's clean energy portfolio of ~18.5 GWs on a gross basis as of June 16, 2025, is one of the largest globally. In addition to being a major independent power producer in India, we provide end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. For more information, visit and follow us on LinkedIn, Facebook, Twitter and Instagram.


Business Wire
an hour ago
- Business Wire
Exchange Income Corporation Announces Commitment to Expand the Atik Mason Indigenous Pilot Pathway in Nunavut
WINNIPEG, Manitoba--(BUSINESS WIRE)--Exchange Income Corporation (TSX: EIF) ('EIC' or the 'Corporation') a diversified, acquisition-oriented company focused on opportunities in the Aerospace & Aviation and Manufacturing segments, announces it will commit to double the capacity of its Atik Mason Indigenous Pilot Pathway in Nunavut for 2026 (the 'Program'). The Program removes significant barriers to flight training faced by Indigenous students including cost and location and honors the importance of retaining a deep connection to Indigenous culture while training. The Program was initially established in 2022 in Thompson, Manitoba and was expanded to Rankin Inlet, Nunavut in 2024 which is the first and only of its kind in Nunavut. With the completion of the acquisition of Canadian North which expands our footprint in Nunavut, the doubling of the capacity of the Program in Nunavut for next year was an obvious and natural choice for EIC and consistent with the Corporation's history of investing in the communities we serve. 'We take seriously our responsibility to invest in the regions which we serve. This is why we originally expanded the Program to Rankin Inlet where it has been remarkably successful with the first student starting to fly for us this year and five others will be completing their training in 2026 with jobs waiting for them at our airlines,' stated Mike Pyle, CEO of EIC. He continued, 'With the acquisition of Canadian North we are thrilled to be materially expanding the Program in Nunavut and see many more Inuit joining our companies as pilots. Through this expansion we will not only invest in the assets needed in Nunavut to support the Program's growth but also invest in the Inuit living in the communities. They are our future pilots. These types of investments are a cornerstone of who is EIC is, how we operate and what will continue to drive our success operating in the North.' About Exchange Income Corporation Exchange Income Corporation is a diversified acquisition-oriented company, focused in two segments: Aerospace & Aviation and Manufacturing. The Corporation uses a disciplined acquisition strategy to identify already profitable, well-established companies that have strong management teams, generate steady cash flow, operate in niche markets and have opportunities for organic growth. For more information on the Corporation, please visit Additional information relating to the Corporation, including all public filings, is available on SEDAR+ ( Caution concerning forward-looking statements The statements contained in this news release that are forward-looking are based on current expectations and are subject to a number of uncertainties and risks, and actual results may differ materially. Many of these forward-looking statements may be identified by looking for words such as 'believes', 'expects', 'will', 'may', 'intends', 'projects', 'anticipates', 'plans', 'estimates', 'continues' and similar words or the negative thereof. These uncertainties and risks include, but are not limited to, external risks, operational risks, financial risks and human capital risks. External risks include, but are not limited to, risks associated with economic and geopolitical conditions, competition, government funding for Indigenous health care, access to capital, market trends and innovation, general uninsured loss, climate, acts of terrorism, armed conflict, labour and/or social unrest, pandemic, level and timing of government spending, government-funded programs and environmental, social and governance. Operational risks include, but are not limited to, significant contracts and customers, operational performance and growth, laws, regulations and standards, acquisitions (including receiving any requisite regulatory approvals thereof), concentration and diversification, maintenance costs, access to parts and relationships with key suppliers, casualty losses, environmental liability, dependence on information systems and technology, cybersecurity, international operations, fluctuations in sales prices of aviation related assets, fluctuations in purchase prices of aviation related assets, warranty, performance guarantees, global offset and intellectual property risks. Financial risks include, but are not limited to, availability of future financing, income tax matters, commodity risk, foreign exchange, interest rates, credit facility and the trust indentures, dividends, unpredictability and volatility of securities pricing, dilution and other credit risk. Human capital risks include, but are not limited to, reliance on key personnel, employees and labour relations and conflicts of interest. Except as required by Canadian Securities Law, Exchange Income Corporation does not undertake to update any forward-looking statements; such statements speak only as of the date made. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by Exchange Income Corporation with the securities regulatory authorities, available at